As demand for global equities grows, Antipodes Partners expands

As demand for global equities grows, Antipodes Partners expands
• appoints managing director
• additional hires expand investment team
• plans active ETF

Sydney 5 April 2018: Leading investment boutique Antipodes Partners has been a big beneficiary of increased demand from local investors, both institutional and retail, for global equities over the past year.

Its assets under management (AUM) has increased to ~$7 billion in just three years since its formation – with around half being sourced from institutions and half from retail investors (including SMSFs and high net worth individuals).

In line with its significant growth, Antipodes has appointed Andrew Findlay as dedicated Managing Director to oversee the firm’s business activities. Andrew was previously a senior executive at minority partner Pinnacle Investment Management.

Jacob Mitchell, Founder and Chief Investment Officer of Antipodes, said: “Andrew has been instrumental to Antipodes’ success since day one and I’m delighted he’s accepted the role of Managing Director. Based on my experience, it’s best to separate the functions of investing and business management. Antipodes is a performance-driven firm and my time is best spent leading our growing investment team.”

Antipodes is also expanding its investment team in Sydney and in London where it recently opened a dedicated research office.

Kieran Rabbitt has been appointed as Investment Specialist, responsible for portfolio analytics and systems development expanding Antipodes’ quant/macro team to four. He previously spent eight years at Dimensional Fund Advisors.

Aidan Kerr has been appointed as an Investment Analyst covering the global healthcare sector. Previously, Aidan was an equity analyst in the healthcare team at Magellan Financial Group and he has also worked for AstraZeneca, Accenture and as a Research Scientist at the University of New South Wales.

Vinayak Muralidharan has been appointed as an Investment Analyst covering the global financials and infrastructure sectors. Before joining Antipodes, Vinayak spent seven years with Magellan Financial Group as an equities analyst focused on global banks and diversified financials and four years with Ernst & Young.

Mr Mitchell said: “With strong growth in our business and an investment-led culture, we’ve become an employer of choice for talented investment professionals who want to further
their career in global equities. I’m delighted with the calibre of our recent hires which take our investment team to 17 professionals, of which three are based in London.”

In keeping with its founding principle of maintaining a focused investment approach, Antipodes is also launching additional investment vehicles for its existing global equity
strategies.

One is an actively-managed ETF, also known as an ‘exchange quoted managed fund’ (EQMF). The new EQMF is expected to launch within the next two months and will enable SMSFs and other retail investors to easily access Antipodes’ capabilities through an openended ASX-listed investment.

Antipodes has also launched Irish-domiciled UCITS funds for its global equity strategies. The UCITS funds are targeted towards investors in Europe and Asia where Antipodes is seeing demand for its high-conviction, risk-aware approach.

Mr Findlay added: “The investment team has the advantage of managing a focused number of investment strategies. At the same time we are developing new vehicles to provide access to a broader spectrum of investors, both in Australia and overseas.”

Back to NEWS